Nuveen LLC acquired a new position in shares of Clarivate PLC (NYSE:CLVT - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,385,090 shares of the company's stock, valued at approximately $5,443,000. Nuveen LLC owned about 0.20% of Clarivate at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of CLVT. LPL Financial LLC purchased a new stake in shares of Clarivate during the 4th quarter worth approximately $115,000. Tower Research Capital LLC TRC lifted its position in shares of Clarivate by 34.9% during the 4th quarter. Tower Research Capital LLC TRC now owns 27,995 shares of the company's stock worth $142,000 after buying an additional 7,247 shares during the last quarter. Dark Forest Capital Management LP purchased a new stake in shares of Clarivate during the 4th quarter worth approximately $219,000. Oxford Asset Management LLP purchased a new stake in shares of Clarivate during the 4th quarter worth approximately $247,000. Finally, Public Employees Retirement Association of Colorado purchased a new stake in shares of Clarivate during the 4th quarter worth approximately $194,000. Hedge funds and other institutional investors own 85.72% of the company's stock.
Insider Buying and Selling at Clarivate
In other news, insider James Gordon Samson sold 100,000 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $4.53, for a total transaction of $453,000.00. Following the transaction, the insider directly owned 1,271,103 shares of the company's stock, valued at $5,758,096.59. This represents a 7.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 23.18% of the stock is currently owned by company insiders.
Clarivate Price Performance
Shares of NYSE:CLVT traded up $0.07 on Friday, reaching $4.38. 4,740,005 shares of the company were exchanged, compared to its average volume of 4,651,243. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.90. Clarivate PLC has a 1-year low of $3.04 and a 1-year high of $7.15. The firm has a market cap of $2.94 billion, a price-to-earnings ratio of -7.06 and a beta of 1.40. The company has a 50-day moving average of $4.25 and a 200-day moving average of $4.16.
Clarivate (NYSE:CLVT - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.18 earnings per share for the quarter, hitting analysts' consensus estimates of $0.18. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. The business had revenue of $621.40 million for the quarter, compared to analysts' expectations of $587.17 million. During the same period in the prior year, the company posted $0.20 EPS. The business's revenue for the quarter was down 4.4% on a year-over-year basis. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. Equities analysts forecast that Clarivate PLC will post 0.63 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several research firms recently commented on CLVT. Jefferies Financial Group began coverage on shares of Clarivate in a research report on Friday, July 18th. They issued a "hold" rating and a $4.50 price target for the company. Wall Street Zen downgraded shares of Clarivate from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Three equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Reduce" and an average target price of $4.83.
Check Out Our Latest Report on CLVT
Clarivate Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Further Reading

Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.